Emmecell Appoints Ramin Valian as Chief Executive Officer to Advance Magnetic Cell Delivery Platform [Yahoo! Finance]
AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Five Takeaways From The 2026 J.P. Morgan Healthcare Conference [Forbes]
AbbVie Inc.'s (NYSE:ABBV) institutional investors lost 3.3% last week but have benefitted from longer-term gains [Yahoo! Finance]
AbbVie (NYSE:ABBV) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.